Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the ...

Ginkgo provides update on its restructuring process including an acceleration of site consolidation initiatives and continued progress on cost reductions Ginkgo signs ...

In a report released yesterday, Jason Zemansky from Bank of America Securities maintained a Hold rating on Arcus Biosciences (RCUS – ...

Taking a new tack There's no word yet on the drug targets that will be explored in the Cerevance partnership, but Merck head of neuroscience discovery, Jason Uslaner, said that the collaboration ...

Updated clinical data from VISTA101 presented at SITC 2024.Monotherapy arm fully enrolled and combination arm expected to be fully enrolled by ...

Teledyne Technologies Incorporated today announced that George Bobb, President and Chief Operating Officer, and Jason VanWees, Vice Chairman, will participate at the Baird 2024 Global Industrial ...

The attacker was later identified as a 45-year-old David Merck, and had punched the actress in the face ... Bull and featured ...

Joel Richardson, Vice President of Public Relations at Cooke Aquaculture Inc. has been elected as CAIA's new Board Chair.

Collaborations: Mersana continues to advance its Johnson & Johnson and Merck KGaA, Darmstadt, Germany collaborations. The ...

Plan to announce initial clinical data for XMT-1660 at a company event by the end of 2024 Dose escalation advancing in Phase 1 clinical trial of XMT-2056 Conference call today at 8:00 a.m. ET CAMBRIDG ...

Former Philadelphia Eagles All-Pro center Jason Kelce was involved in an incident with an unruly fan who used homophobic slurs to describe his brother, Kansas City Chiefs tight end Travis Kelce.

Merck booked just under $600 million last year in alliance revenues from the pair, but its attention is now moving to new therapies including sotatercept, a TGF-beta-targeting PAH drug Merck ...